Hollow fiber liquid-phase microextraction combined with high performance liquid chromatography for the determination of trace mitiglinide in biological fluids

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 895-896, Issue , 2012, Pages 131-136

  Hadi, Hind ^a,b   Makahleh, Ahmad ^a   Saad, Bahruddin ^a  

^a SCHOOL OF PHYSICS   (Malaysia)

^b UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

Biological fluids; High performance liquid chromatography; Hollow fiber liquid phase microextraction; Mitiglinide

Indexed keywords

ACCEPTOR PHASE; ANTIDIABETIC DRUG; AQUEOUS SAMPLES; BACK EXTRACTION; BIOLOGICAL FLUIDS; CONCENTRATION LEVELS; DETECTION LIMITS; ENRICHMENT FACTORS; EXTRACTION CONDITIONS; EXTRACTION EFFICIENCIES; EXTRACTION TIME; HOLLOW FIBER; HOLLOW FIBER LIQUID PHASE MICROEXTRACTION; HPLC-UV; LIQUID PHASE MICROEXTRACTION; MITIGLINIDE; ORGANIC PHASE; PLASMA SAMPLES; RELATIVE STANDARD DEVIATIONS; REVERSED PHASE; SALT ADDITION; SPIKED SAMPLES; STIRRING RATES; TRACE AMOUNTS;

BODY FLUIDS; CHROMATOGRAPHY; FIBERS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUIDS; OPTIMIZATION; ORGANIC SOLVENTS; TRACE ANALYSIS;

SOLVENT EXTRACTION;

MITIGLINIDE; ORGANIC SOLVENT;

AQUEOUS SOLUTION; ARTICLE; BODY FLUID; HOLLOW FIBER; HUMAN; LIQUID PHASE MICROEXTRACTION; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET RADIATION; URINE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; HYDROGEN-ION CONCENTRATION; ISOINDOLES; LINEAR MODELS; LIQUID PHASE MICROEXTRACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SODIUM CHLORIDE;

EID: 84860152616     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2012.03.031     Document Type: Article

References (29)

1. Bergenstal R.M., Gavin J.R. Am. J. Med. 2005, 118:1S.
2. Blonde L., Karter A.J. Am. J. Med. 2005, 118:20S.
3. Vashist S.K., Zheng D., Al-Rubeaan K., Luong J.H.T., Sheu F.-S. Anal. Chim. Acta 2011, 703:124.
4. Sunaga Y., Gonoi T., Shibasaki T., Ichikawa K., Kusama H., Yano H., Seino S. Eur. J. Pharmacol. 2001, 431:119.
5. Reimann F., Proks P., Ashcroft F.M. Br. J. Pharmacol. 2001, 132:1542.
6. McLeod J.F. Clin. Pharmacokinet. 2004, 43:97.
7. Phillippe H.M., Wargo K.A. Ann. Pharmacother. 2010, 44:1615.
8. Lushan Y., Su Z. J. Chromatogr. B 2006, 834:204.
9. Zhang Y., Ding L., Tian Y., Yang J., Yang L., Wen A. Biomed. Chromatogr. 2008, 22:873.
10. Liang Y., Sun J., Xie L., Kang A., Xie Y., Chen W.D., Lv H., Wang G.-J. Chromatographia 2007, 66:165.
11. Liang J., Tian Y., Zhang Z., Feng S., Zhao Y., Mao G. J. Mass Spectrom. 2007, 42:171.
12. Cai S., Huo T., Feng W., Chen L., Qin F., Li F. J. Chromatogr. B 2008, 868:83.
13. Pedersen-Bjergaard S., Rasmussen K.E. Anal. Chem. 1999, 71:2650.
14. Richoll S.M., Colón I. J. Chromatogr. A 2006, 1127:147.
15. Payán M.R., López M.B., Fernández-Torres R., Navarro M.V., Mochón M.C. Talanta 2009, 79:911.
16. http://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL471498.
17. Blicklé J.F. Diabetes Metab. 2006, 32:113.
18. Wen J.H., Xiong Y.Q. Chromatographia 2009, 70:1715.
19. Kemnitz C.R., Loewen M.J. J. Am. Chem. Soc. 2007, 129:2521.
20. Smith M.B., March J. Advanced Organic Chemistry 2001, John Wiley, New York. 5th ed.
21. Carey F.A. Organic Chemistry 1996, McGraw-Hill, New York. 3rd ed.
22. Zhao L., Lee H.K. Anal. Chem. 2002, 74:2486.
23. Shen G., Lee H.K. Anal. Chem. 2002, 74:648.
24. Magalhães I.R.S., Bonato P.S. J. Pharm. Biomed. Anal. 2008, 46:929.
25. Saaid M., Saad B., Ali A.S.M., Saleh M.I., Basheer C., Lee H.K. J. Chromatogr. A 2009, 1216:5165.
26. Esrafili A., Yamini Y., Shariati S. Anal. Chim. Acta 2007, 604:127.
27. Al Azzam K.M., Makahleh A., Saad B., Mansor S.M. J. Chromatogr. A 2010, 1217:3654.
28. Sobhi H.R., Yamini Y., Abadi R.H.B. J. Pharm. Biomed. Anal. 2007, 45:769.
29. Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, 2001. http://www.fda.gov/cder/guidance/index.htm.